Cardiological parameters predict mortality and cardiotoxicity in oncological patients.
Sebastian W RomannDaniel FinkeMarkus B HeckmannHauke HundEvangelos GiannitsisHugo A KatusNorbert FreyLorenz H LehmannPublished in: ESC heart failure (2023)
In cancer patients, CVRF accumulation predicts cardiotoxicity whereas elevated hs-cTnT or NT-proBNP levels are associated with ACM. Accordingly, less intensive surveillance protocols may be warranted in patients with low cardiac biomarker levels and absence of CVRFs.